A bi-partisan proposal has been made through the House of Representatives that aims to strengthen the Food and Drug Administration’s (FDA) ability to regulate cosmetic products.
Activist investor William Ackman says he believes Procter & Gamble’s fortunes will rebound significantly in the space of the next, but criticized the company’s CEO, Robert McDonald.
